Journal
JOURNAL OF ENDOCRINOLOGY
Volume 201, Issue 3, Pages 309-320Publisher
BIOSCIENTIFICA LTD
DOI: 10.1677/JOE-08-0568
Keywords
-
Categories
Funding
- GlaxoSmithKline Clinician Scientist Fellowship
- Arthritis Research Campaign [18081]
Ask authors/readers for more resources
Chronic inflammatory diseases of almost any cause are associated with bone loss. Bone loss is due to direct effects of inflammation, poor nutrition, reduced lean body mass, immobility and the effects of treatments, especially glucocorticoids. These mechanisnis are complex and interrelated but are ultimately mediated through effects oil the bone remodelling cycle. Inflammatory disease call increase bone resorption, decrease bone formation but most commonly impacts on both of these processes resulting in all uncoupling of bone formation from resorption in favour of excess resorption. This review will illustrate these interactions between inflammation and bone metabolism and discuss how these are, and might be, manipulated as therapies for inflammation related bone loss. Journal of Endocrinology (2009) 201, 309-320
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available